BFS
JAZZ icon

Bare Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bare Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.75K Buy
28
+1
+4% +$219 ﹤0.01% 746
2026
Q1 		$5.1K Buy
27
+8
+42% +$1.4K ﹤0.01% 633
2025
Q4 		$3.23K Buy
19
+5
+36% +$767 ﹤0.01% 696
2025
Q3 		$1.84K Sell
14
-32
-70% -$3.84K ﹤0.01% 832
2025
Q2 		$4.88K Buy
+46
New +$5K ﹤0.01% 497

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bare Financial Services's JAZZ Position: Q2 2026 in Review

Bare Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 3.7% in Q2 2026, buying an estimated $219 and bringing the position to 28 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Bare Financial Services first reported a position in JAZZ in Q2 2025 and has held it in 5 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Bare Financial Services held 28 shares of Jazz Pharmaceuticals worth $6.75K as of Q2 2026.
  • Bare Financial Services bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
  • Jazz Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #746 holding.
  • Bare Financial Services first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.